Papilloma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: PPL022 MIFTS: 58	Papilloma Categories: Cancer diseases
Genes Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Papilloma

MalaCards integrated aliases for Papilloma:

Name: Papilloma ¹² ⁵⁵ ¹⁵ ⁷³

Papillomatosis ¹² ⁵⁵ ⁷³

Classifications:

MalaCards categories:
Global: Cancer diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:2615

MeSH ⁴⁴ D010212

NCIt ⁵⁰ C3713 C7440

SNOMED-CT ⁶⁸ 189564006 23730008 711329002 more

UMLS ⁷³ C0030354 C0205875

Sources

Summaries for Papilloma

Disease Ontology : ¹² A cell type benign neoplam that is composed_of epithelial tissue on papillae of vascularized connective tissue.

MalaCards based summary : Papilloma, also known as papillomatosis, is related to inverted papilloma and bladder transitional cell papilloma. An important gene associated with Papilloma is TP53 (Tumor Protein P53), and among its related pathways/superpathways are Developmental Biology and Cellular Senescence (REACTOME). The drugs Cervarix and Cidofovir have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and cervix, and related phenotypes are growth/size/body region and cellular

Wikipedia : ⁷⁶ A papilloma (plural papillomas or papillomata) (papillo- + -oma) is a benign epithelial tumor growing... more...

Sources

Related Diseases for Papilloma

Diseases related to Papilloma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 416)

#	Related Disease	Score	Top Affiliating Genes
1	inverted papilloma	34.5	CDKN2A KRT13 KRT20 TP53
2	bladder transitional cell papilloma	34.5	CDKN1A TP53
3	frontal sinus inverted papilloma	34.3	KRT13 KRT5
4	inverted transitional papilloma	34.1	CDKN2A KRT5
5	anogenital venereal wart	33.3	CDKN2A TP53 UBE3A
6	urinary tract papillary transitional cell benign neoplasm	33.0	KRT20 TP53
7	li-fraumeni syndrome	32.4	CDKN1A CDKN2A PTEN TP53
8	oral cancer	31.2	CDKN2A KRT13 TP53
9	suppressor of tumorigenicity 3	31.1	CDKN1A CDKN2A RB1 TP53 UBE3A
10	cervical cancer	31.1	CDKN1A CDKN2A PTEN RB1 TP53 UBE3A
11	retinoblastoma	30.9	CDKN1A CDKN2A RB1 TP53
12	adenocarcinoma	30.8	CDKN2A PTEN RB1 TP53
13	cervical squamous cell carcinoma	30.8	CDKN2A KRT8 TP53
14	bowenoid papulosis	30.7	CDKN2A FLG
15	vulvar intraepithelial neoplasia	30.7	KRT5 TP53
16	tongue cancer	30.7	CDKN1A CDKN2A KRT13 TP53
17	transitional cell carcinoma	30.6	CDKN2A KRT20 KRT8 PTEN TP53
18	lymphoepithelioma-like carcinoma	30.6	KRT20 KRT5 KRT8
19	schneiderian carcinoma	30.5	CDKN2A KRT5 TP53
20	bladder squamous cell carcinoma	30.5	CDKN2A PTEN TP53
21	endometrial adenocarcinoma	30.5	CDKN2A PTEN TP53
22	adenosquamous carcinoma	30.4	KRT5 KRT8 TP53
23	keratoacanthoma	30.3	CDKN1A FLG KRT10 TP53
24	cervical adenocarcinoma	30.3	CDKN1A CDKN2A KRT20 TP53
25	ductal carcinoma in situ	30.3	KRT14 KRT5 KRT8 TP53
26	bladder cancer	30.2	CDKN1A CDKN2A KRT20 RB1 TP53
27	squamous cell carcinoma, head and neck	30.2	CDKN1B CDKN2A PTEN RB1 TP53
28	epidermodysplasia verruciformis	30.2	CDKN2A KRT10 KRT14
29	actinic keratosis	30.2	CDKN2A FLG KRT20 TP53
30	basaloid squamous cell carcinoma	30.1	CDKN2A KRT13 KRT14 KRT8 TP53
31	squamous cell carcinoma	30.0	CDKN1B CDKN2A IVL PTEN RB1 TP53
32	in situ carcinoma	29.8	CDKN2A KRT14 KRT5 TP53
33	small cell cancer of the lung	29.7	CDKN2A KRT20 PTEN RB1 TP53
34	ichthyosis vulgaris	29.4	FLG KRT10 KRT14
35	adenoid cystic carcinoma	29.3	KRT14 KRT20 PTEN TP53
36	keratosis	29.3	FLG IVL KRT10
37	lichen planus	29.3	FLG IVL KRT10 KRT13 TP53
38	large cell acanthoma	29.2	KRT10 KRT14 KRT5
39	glioblastoma	29.1	CDKN1A CDKN1B CDKN2A CDKN2B PTEN RB1
40	esophageal cancer	29.0	CDKN1A CDKN1B CDKN2A CDKN2B FSCN1 PTEN
41	basal cell carcinoma	26.9	CDKN1A IVL KRT10 KRT14 KRT20 KRT8
42	papilloma of choroid plexus	12.5
43	squamous cell papilloma	12.3
44	intraductal papilloma	12.2
45	skin papilloma	12.0
46	atypical choroid plexus papilloma	12.0
47	transitional papilloma	12.0
48	breast duct papilloma	12.0
49	ureter inverted papilloma	12.0
50	maxillary sinus inverted papilloma	11.9

Graphical network of the top 20 diseases related to Papilloma:

Sources

Symptoms & Phenotypes for Papilloma

MGI Mouse Phenotypes related to Papilloma:

⁴⁶ (show all 14)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	growth/size/body region	MP:0005378	10.29	CDKN1B FSCN1 AMOT CDKN2A CDKN1A TP53
2	cellular	MP:0005384	10.28	CDKN2A CDKN1A CDKN2B FSCN1 CDKN1B AMOT
3	embryo	MP:0005380	10.21	CDKN1B FSCN1 AMOT CDKN2A CDKN1A TP53
4	mortality/aging	MP:0010768	10.21	CDKN2B CDKN1B FSCN1 AMOT CDKN2A CDKN1A
5	digestive/alimentary	MP:0005381	10.18	CDKN1B CDKN2A CDKN1A TP53 PTEN KRT14
6	endocrine/exocrine gland	MP:0005379	10.15	CDKN2A CDKN1A CDKN2B CDKN1B PTEN KRT14
7	integument	MP:0010771	10.13	CDKN2B CDKN1B KRT14 CDKN2A CDKN1A TP53
8	liver/biliary system	MP:0005370	9.95	CDKN2A CDKN1A CDKN1B KRT8 PTEN RB1
9	hearing/vestibular/ear	MP:0005377	9.93	CDKN1A CDKN1B KRT8 KRT14 RB1 TP53
10	neoplasm	MP:0002006	9.92	CDKN2B CDKN1B CDKN2A CDKN1A TP53 PTEN
11	no phenotypic analysis	MP:0003012	9.86	CDKN2A CDKN1A CDKN2B CDKN1B RB1 KRT5
12	reproductive system	MP:0005389	9.65	CDKN2A CDKN1A CDKN2B CDKN1B KRT8 TP53
13	pigmentation	MP:0001186	9.63	CDKN1B CDKN2A TP53 PTEN KRT14 RB1
14	respiratory system	MP:0005388	9.17	CDKN2A CDKN1A CDKN1B RB1 PTEN KRT14

Sources

Drugs & Therapeutics for Papilloma

FDA approved drugs:

#	Drug Name	Active Ingredient(s) ¹⁸	Company	Approval Date
1	Cervarix ¹⁸ ⁴⁹	Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant	GlaxoSmithKline	October 2009
FDA Label: Cervarix Disease/s that Drug Treats:prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18 Indications and Usage: ¹⁸ DrugBank Targets: - Mechanism of Action: ¹⁸ Target: IgG neutralizing antibodies directed against HPV-L1 capsid proteins Action: activates/ provokes production FDA: -

Drugs for Papilloma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 257)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Cidofovir

Approved

Phase 4,Phase 2,Phase 1

113852-37-2

60613

Chlorhexidine

Approved, Vet_approved

Phase 4

55-56-1

9552079 2713

Imiquimod

Approved, Investigational

Phase 4,Phase 2,Phase 3,Phase 1

99011-02-6

57469

Liver Extracts

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Vaccines

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Anti-Infective Agents

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Antiviral Agents

Phase 4,Phase 3,Phase 2,Phase 1

Antibodies

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Immunoglobulins

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Anti-Infective Agents, Local

Phase 4

Chlorhexidine gluconate

Phase 4

Dermatologic Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Disinfectants

Phase 4

Hypoglycemic Agents

Phase 4

Polyhexamethylene biguanide

Phase 4

Heptavalent Pneumococcal Conjugate Vaccine

Phase 4

MF59 oil emulsion

Phase 4

Adjuvants, Immunologic

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Interferon Inducers

Phase 4,Phase 2,Phase 3,Phase 1

interferons

Phase 4,Phase 2,Phase 3,Phase 1

Azithromycin

Approved

Phase 3,Not Applicable

83905-01-5

55185 447043

Cetuximab

Approved

Phase 3,Phase 1,Phase 2,Not Applicable

205923-56-4

56842117 2333

Benzocaine

Approved, Investigational

Phase 3

1994-09-7, 94-09-7

2337

Penicillin G

Approved, Vet_approved

Phase 3

61-33-6

5904

Fentanyl

Approved, Illicit, Investigational, Vet_approved

Phase 3

437-38-7

3345

Fluconazole

Approved, Investigational

Phase 2, Phase 3

86386-73-4

3365

Miconazole

Approved, Investigational, Vet_approved

Phase 2, Phase 3,Phase 1

22916-47-8

4189

Cevimeline

Approved

Phase 3

107233-08-9

83898 25137844

Megestrol acetate

Approved, Investigational, Vet_approved

Phase 3

595-33-5

11683

Doxepin

Approved, Investigational

Phase 3

1668-19-5

667477 667468

Histamine

Approved, Investigational

Phase 3,Phase 2

75614-87-8, 51-45-6

774

Cisplatin

Approved

Phase 3,Phase 2,Phase 1,Not Applicable

15663-27-1

84093 441203 2767

Fluorouracil

Approved

Phase 3,Phase 2,Phase 1

51-21-8

3385

Docetaxel

Approved, Investigational

Phase 3,Phase 1,Phase 2

114977-28-5

148124

Zinc

Approved, Investigational

Phase 3,Not Applicable

7440-66-6

23994

Zinc sulfate

Approved, Investigational

Phase 3,Not Applicable

7733-02-0

tannic acid

Approved, Nutraceutical

Phase 3

Pancreatic Polypeptide

Investigational

Phase 3

59763-91-6

Lapatinib

Approved March 2007, Investigational

Phase 3,Phase 2

231277-92-2, 388082-78-8

208908 9941095

Anti-Bacterial Agents

Phase 3,Phase 2,Phase 1,Not Applicable

Cytochrome P-450 Enzyme Inhibitors

Phase 2, Phase 3

Immunosuppressive Agents

Phase 3,Phase 1,Phase 2,Not Applicable

Pharmaceutical Solutions

Phase 3,Phase 2,Not Applicable

Antibiotics, Antitubercular

Phase 3,Phase 2,Phase 1

Penicillin G Benzathine

Phase 3

Penicillin G Procaine

Phase 3

Adjuvants, Anesthesia

Phase 3

Analgesics

Phase 3,Phase 2,Phase 1

Analgesics, Opioid

Phase 3

Anesthetics

Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 392)

#	Name	Status	NCT ID	Phase	Drugs
1	Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?	Unknown status	NCT01101750	Phase 4
2	Use of Cidofovir for Recurrent Respiratory Papillomatosis	Completed	NCT00205374	Phase 4	Cidofovir;Placebo
3	A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men	Completed	NCT01431079	Phase 4
4	Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine	Completed	NCT01740245	Phase 4
5	Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls	Completed	NCT00956553	Phase 4
6	Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease	Completed	NCT00815282	Phase 4
7	Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents	Completed	NCT00534638	Phase 4
8	MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine	Completed	NCT02225327	Phase 4
9	Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years	Completed	NCT02215863	Phase 4
10	Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)	Recruiting	NCT03391921	Phase 4
11	Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts	Recruiting	NCT03183765	Phase 4	Measles-Mumps-Rubella Vaccine
12	Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients	Active, not recruiting	NCT02624349	Phase 4	Quadravalent human papillomavirus vaccine
13	HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)	Active, not recruiting	NCT02087384	Phase 4	Placebo
14	Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination	Not yet recruiting	NCT03350698	Phase 4
15	The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts	Not yet recruiting	NCT03477448	Phase 4	Bleomycin;Purified Protein Derivative
16	Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")	Terminated	NCT00747461	Phase 4
17	Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV	Withdrawn	NCT01663558	Phase 4	imiquimod
18	Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City	Unknown status	NCT02382900	Phase 3
19	4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children	Unknown status	NCT01995721	Phase 3
20	Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination	Completed	NCT00964210	Phase 3	Licensed quadrivalent HPV vaccine, Gardasil
21	Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine	Completed	NCT00316706	Phase 3
22	Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.	Completed	NCT00196924	Phase 3
23	Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18	Completed	NCT00169494	Phase 3
24	Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)	Completed	NCT00380367	Phase 3
25	Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18	Completed	NCT00122681	Phase 3
26	Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18	Completed	NCT00196937	Phase 3
27	Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)	Completed	NCT01862874	Phase 3
28	Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women	Completed	NCT00337818	Phase 3
29	A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men	Completed	NCT02114385	Phase 3
30	A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)	Completed	NCT00090220	Phase 3
31	Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years	Completed	NCT00345878	Phase 3
32	Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women	Completed	NCT00344032	Phase 3
33	Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age	Completed	NCT00423046	Phase 3
34	Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)	Completed	NCT00157950	Phase 3
35	Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects	Completed	NCT00578227	Phase 3
36	A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years	Completed	NCT00485732	Phase 3
37	A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)	Completed	NCT00092547	Phase 3
38	Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls	Completed	NCT01381575	Phase 3
39	Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age	Completed	NCT00552279	Phase 3
40	ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial	Completed	NCT00941252	Phase 2, Phase 3	Topical imiquimod therapy
41	A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008).	Completed	NCT01254643	Phase 3
42	Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea	Completed	NCT01955252	Phase 3	Azithromycin
43	Glizigen-Viudid-External Anogenital Warts in Children and Adolescents	Completed	NCT01111344	Phase 3
44	Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age	Completed	NCT00492544	Phase 3
45	Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years	Completed	NCT00456807	Phase 3
46	A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls	Completed	NCT02562508	Phase 3
47	A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix	Completed	NCT00264732	Phase 2, Phase 3	Amolimogene;Amolimogene
48	Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts	Completed	NCT00735462	Phase 3	2.5% imiquimod cream;3.75% imiquimod cream;Placebo cream
49	Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia	Completed	NCT01164722	Phase 3
50	Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain	Completed	NCT00538850	Phase 3	Fentanyl sublingual spray;Placebo

Search NIH Clinical Center for Papilloma

Inferred drug relations via UMLS ⁷³ / NDF-RT ⁵¹ :

podophyllin

podophyllin pwdr

Sources

Genetic Tests for Papilloma

Sources

Anatomical Context for Papilloma

MalaCards organs/tissues related to Papilloma:

⁴¹

Testes, Skin, Cervix, Lung, Kidney, Breast, Brain

Sources

Publications for Papilloma

Articles related to Papilloma:

(show top 50) (show all 1945)

#	Title	Authors	Year
1	Clinical features of nasal and sinonasal inverted papilloma associated with malignancy. ( 29548524 )	Miyazaki T....Tamaki H.	2018
2	Malignant Transformation of a Canine Papillomavirus Type 1-Induced Persistent Oral Papilloma in a 3-Year-Old Dog. ( 29865982 )	Regalado Ibarra A.M....Munday J.S.	2018
3	Degenerated Keratinized Tumor Cells in Oropharyngeal Human Papilloma Virus-Associated Squamous Cell Carcinoma: A Pitfall in p16 Immunostaining of Fine-Needle Aspiration Specimens. ( 29966127 )	Wei S....Ehya H.	2018
4	Human Papilloma Virus and Autophagy. ( 29914057 )	Mattoscio D....Chiocca S.	2018
5	Genotype patterns and prevalence of human papilloma virus in non-vaccinated women in Zunyi, China. ( 29915851 )	Zhao Y....Liu X.	2018
6	Human Papilloma Virus 16/18: Fabricator of Trouble in Oral Squamous Cell Carcinoma. ( 29432879 )	Zil-E-Rubab ....Lucky M.H.	2018
7	Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. ( 29449057 )	Yap M.L....Milosevic M.	2018
8	Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification. ( 29422018 )	Rohatensky M.G....van Marle G.	2018
9	Human papilloma virus-specific T cells can be generated from naA^ve T cells for use as an immunotherapeutic strategy for immunocompromised patients. ( 29331266 )	McCormack S.E....Bollard C.M.	2018
10	Improving human papilloma virus vaccination rates throughout military treatment facilities. ( 29433899 )	Dawson R....Hansen S.	2018
11	Intraductal papilloma arising from the accessory parotid gland: A case report and literature review. ( 29768362 )	Sun S....Yang H.	2018
12	Laryngeal squamous cell papilloma is highly associated with human papillomavirus. ( 29447361 )	Orita Y....Sato Y.	2018
13	Detection of urinary Chlamydia trachomatis, Mycoplasma genitalium and human papilloma virus in the first trimester of pregnancy by PCR method. ( 29866110 )	Rahimkhani M....Gilanpour M.	2018
14	DNA fragmentation index and human papilloma virus in males with previous assisted reproductive technology failures. ( 29975635 )	Tangal S....YararbaA9 K.	2018
15	Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer. ( 29969771 )	Patel M.R....Aiken A.H.	2018
16	Detection of Epstein-Barr and Human Papilloma Viruses in the Middle Ear Squamous Cell Carcinoma. ( 29456946 )	Surono A....Samodra E.	2018
17	Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review. ( 29333935 )	Meggiolaro A....La Torre G.	2018
18	Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl. ( 29434138 )	Hikiami R....Takahashi R.	2018
19	Mammographic and ultrasound findings in poroid hidradenoma of the breast mimicking intraductal papilloma and papillary carcinoma: A case report. ( 29924021 )	Choi B.H....Choi N.	2018
20	Extensive Mucocutaneous Papillomas in a Case of Focal Dermal Hypoplasia. ( 29854650 )	Jose M....Garg A.	2018
21	Better surgical outcome by image-guided navigation system in endoscopic removal of sinonasal inverted papilloma. ( 29678350 )	Ahn S.H....Kim C.H.	2018
22	A unique presentation of an adolescent with disseminated atypical choroid plexus papilloma. ( 29770898 )	RiviA"re R.N....Story E.	2018
23	Genetic mutation analysis of the malignant transformation of sinonasal inverted papilloma by targeted amplicon sequencing. ( 29779136 )	Yasukawa S....Homma A.	2018
24	Knowledge And Perception Of Female Nursing Students About Human Papilloma Virus (Hpv), Cervical Cancer And Attitudes Towards Hpv Vaccination. ( 29979917 )	DAPnmez S....ZeyneloA9lu S.	2018
25	Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). ( 29393378 )	Boda D....Tsatsakis A.M.	2018
26	Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report. ( 29879069 )	Zhang L....Wei Y.	2018
27	Human Papilloma Virus and the Nurse's Role in Education and Prevention. ( 29905584 )	Sherry J.S....Walter M.L.	2018
28	Human Papilloma Virus (HPV) self-sampling: do women accept it? ( 29385850 )	Abdullah N.N....Al-Kubaisy W.	2018
29	Management of Inverted Papilloma During Holmium Laser Enucleation of the Prostate. ( 29545053 )	Tzou D.T....Stoller M.L.	2018
30	Poor Knowledge of Human Papilloma Virus and Vaccination Among Respondents from Three Nigerian States. ( 29922993 )	Eni A.O....Onile-Ere O.A.	2018
31	A Tale of Two Tumors: a Case of Concomitant Esophageal Squamous Papilloma and Granular Cell Tumor. ( 29453760 )	Kline K.T....Parupudi S.	2018
32	Optical coherence tomography and confocal laser scanning microscopy as non-invasive tools in the diagnosis of sinonasal inverted papilloma: a pilot study. ( 29737509 )	A9vA!ri A....Olzowy B.	2018
33	Raman Spectroscopy for Inverted Papilloma: A Proof-of-Concept Study. ( 29763337 )	Mascarella M.A....Tewfik M.A.	2018
34	Knowledge, Decision-Making and Acceptance of Human Papilloma Virus Vaccination among Parents of Primary School Students in Kota Bharu, Kelantan, Malaysia ( 29936724 )	Mohd Sopian M....Wan Mohamad W.M.Z.	2018
35	Endoscopic mucosal resection of rectal squamous cell papilloma. ( 29351698 )	Alkady M.N....Elkholy S.	2018
36	Atypical Presentation of Squamous Papilloma. ( 29342034 )	Patel P....Silkiss R.Z.	2018
37	Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV). ( 29404275 )	Lawson J.S....Glenn W.K.	2018
38	A unique case of a huge mixed squamous cell and glandular papilloma of non-endobronchial origin with a peripheral growth. ( 29977775 )	Yabuki K....Hisaoka M.	2018
39	Use of intraoperative negative margins reduces inverted papilloma recurrence. ( 29336292 )	Miglani A....Lal D.	2018
40	Human papillomavirus: An unlikely etiologic factor in sinonasal inverted papilloma. ( 29668071 )	Mohajeri S....Kilty S.	2018
41	Analysis of miRNA expression profiling identifies miR-214-3p as a novel biomarker in sinonasal inverted papilloma. ( 29952653 )	Teng Y....Li Y.	2018
42	Benign inverted papilloma at bladder neck causing acute urinary retention. ( 29942474 )	Ho L....Kavanagh A.	2018
43	Advancements in electrochemical DNA sensor for detection of human papilloma virus? A review. ( 29981317 )	Rasouli E....Johan M.R.	2018
44	Management of intraductal papilloma without atypia of the breast diagnosed on core biopsy: Size and sampling matter. ( 29687535 )	Symbol B....Ricci A.	2018
45	Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision. ( 29628987 )	Han S.H....Park S.Y.	2018
46	Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: A systematic review and meta-analysis of randomized clinical trials. ( 29794788 )	Zhang W....Li H.	2018
47	Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention. ( 29368102 )	Varman M....Wichman C.	2018
48	Survivin and cortactin expression in sinonasal schneiderian (inverted) papilloma and associated carcinoma. ( 29644904 )	Marioni G....Ottaviano G.	2018
49	Endoscopic management of maxillary sinus inverted papilloma attachment sites to minimize disease recurrence. ( 29618385 )	Wu V....Lee J.M.	2018
50	Sinonasal papilloma: what influences the decision to request a magnetic resonance imaging scan? ( 29909780 )	Kasbekar A.V....Swift A.C.	2018

Sources

Genes for Papilloma

Genes related to Papilloma (0 elite genes):

(show all 35)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	TP53	Tumor Protein P53	Protein Coding	53.26	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Disorders Publications Variants (show sections)	15638389 9178172 11404629 (more) 12597336 10631397 9683277 16142387 10087941 11820603 8625469 17847937 16703747 17685229 8297483 11835811 9215125 10649258 9816227 12534455 1322252 18180113 8813135 8714266 9868114 17116360 8844820 18036045 12960142 15844633 9833779 10226517 8985032 9190999 10851263 10775508 12801837 15077166 9215868 9182527 8817002 8729973 7808793 20395210 18681909 19771278 16624193 11804609 11582581 11115403 11072671 10430900 10197157 9176386 9020379 8563171 10226595 10098744 9724636 9197482 9627712 8968086 8631546 8601524 8044799 15770529 14722112 15033732 12639967 11285227 10220796 10621843 10569807 8608985 7544154 7630643 19411857 19287463 12485898 10884389 10975290 1717923 17545048 17277618 16998598 15659825 12442903 12296755 11867746 8387914 1324797 19084918 17920185 16624261 17373116 17310826 15533911 12497212 12385589 11684723
2	UBE3A	Ubiquitin Protein Ligase E3A	Protein Coding	46.77	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications Gene name Functions (show sections)	17131388 7615550 9182527 (more) 10373495 8004100 7478539 12967322 8563171 16624261
3	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	39.72	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications Functions (show sections)	18958930 10087941 11420459 (more) 15223971 18300235 17277618 7589458 17638654 19562453 17367326 18440161 15668901 18180113 16979303 12507294 12761910 18701516 17414102 17545048 19516893 19084918 18681909 17294450
4	KRT14	Keratin 14	Protein Coding	34.14	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	9856827 16698948 16990761 (more) 9614560 9754566
5	UBE2L3	Ubiquitin Conjugating Enzyme E2 L3	Protein Coding	33.88	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications Proteins (show sections)	8563171 10760570
6	KRT8	Keratin 8	Protein Coding	29.39	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Functions (show sections)
7	KRT13	Keratin 13	Protein Coding	29.13	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	16029072 7679053 7542177
8	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	28.97	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	16703747 10047459 11277421 (more) 11390614 8856306 1737360 9671312 10639830 10617580 10074904 7624142 9215868 12434183
9	RB1	RB Transcriptional Corepressor 1	Protein Coding	28.14	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	18036045 10226595 8058306 (more) 10854068 2151736 7690963 7537374 17977825 12792779 15668901 1309779 11025655 1569054 7591209
10	PTEN	Phosphatase And Tensin Homolog	Protein Coding	27.24	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	17489063
11	AMOT	Angiomotin	Protein Coding	26.89	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Functions (show sections)
12	KRT10	Keratin 10	Protein Coding	26.82	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	16120114
13	KRT5	Keratin 5	Protein Coding	26.26	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	9614560 9242498
14	KRT20	Keratin 20	Protein Coding	26.01	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	10459907 18701516 11144928 (more) 10212826 10874668
15	FLG	Filaggrin	Protein Coding	25.85	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	2337405
16	CDKN2B	Cyclin Dependent Kinase Inhibitor 2B	Protein Coding	24.8	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	10087941
17	CDKN1B	Cyclin Dependent Kinase Inhibitor 1B	Protein Coding	24.05	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	12150617 18036045
18	IVL	Involucrin	Protein Coding	16.28	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11099111
19	HPV18I1	Human Papillomavirus (Type 18) Integration Site 1	Genetic Locus	15.46	GeneCards inferred via : Gene name Functions (show sections)
20	FSCN1	Fascin Actin-Bundling Protein 1	Protein Coding	14.51	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	16084942 17376306
21	IGF2	Insulin Like Growth Factor 2	Protein Coding	13.93	GeneCards inferred via : Publications Functions (show sections)
22	POU4F1	POU Class 4 Homeobox 1	Protein Coding	13.5	Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	9541499
23	POU2F2	POU Class 2 Homeobox 2	Protein Coding	13.5	GeneCards inferred via : Publications Functions (show sections)
24	CD209	CD209 Molecule	Protein Coding	13.5	GeneCards inferred via : Publications Functions (show sections)
25	IL4	Interleukin 4	Protein Coding	13.5	GeneCards inferred via : Publications Functions (show sections)
26	TYMS	Thymidylate Synthetase	Protein Coding	13.5	GeneCards inferred via : Publications Functions (show sections)
27	IFNAR1	Interferon Alpha And Beta Receptor Subunit 1	Protein Coding	13.5	GeneCards inferred via : Publications Functions (show sections)
28	FGFR3	Fibroblast Growth Factor Receptor 3	Protein Coding	13.47	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	12237885 19287463 19621447
29	PCNA	Proliferating Cell Nuclear Antigen	Protein Coding	13.23	Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11820603 12597336 7902669 (more) 18036045 9045891 9139604 11840756 12490112 15039910 17369034 15659825 10226595 12485898 8001934
30	ODC1	Ornithine Decarboxylase 1	Protein Coding	12.6	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
31	KRT7	Keratin 7	Protein Coding	12.42	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
32	SIPA1L1	Signal Induced Proliferation Associated 1 Like 1	Protein Coding	12.2	DISEASES inferred ¹⁵ GeneCards inferred via : Gene name (show sections)
33	KRT1	Keratin 1	Protein Coding	12.2	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
34	CCND1	Cyclin D1	Protein Coding	12.19	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
35	TP63	Tumor Protein P63	Protein Coding	11.91	Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	17295644 18701516 16575508 (more) 16698948

Sources

Variations for Papilloma

Sources

Expression for Papilloma

Search GEO for disease gene expression data for Papilloma.

Sources

Pathways for Papilloma

Pathways related to Papilloma according to GeneCards Suite gene sharing:

(show top 50) (show all 53)

#	Super pathways	Score	Top Affiliating Genes
1	Developmental Biology ⁶⁶ Show member pathways Axon guidance ⁶⁶	13.51	FLG IVL KRT10 KRT13 KRT14 KRT20
2	Cellular Senescence (REACTOME) ⁶⁶ Show member pathways Cellular Senescence ⁶⁶ Oxidative Stress Induced Senescence ⁶⁶ Senescence-Associated Secretory Phenotype (SASP) ⁶⁶	13.14	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53
3	PI3K-Akt signaling pathway ³⁷ Show member pathways Human papillomavirus infection ³⁷	12.98	CDKN1A CDKN1B PTEN RB1 TP53 UBE3A
4	Endometrial cancer ³⁷ Show member pathways Acute myeloid leukemia ³⁷ Binding of TCF/LEF-CTNNB1 to target gene promoters ⁶⁶ Chronic myeloid leukemia ³⁷ Colorectal cancer ³⁷ Pancreatic cancer ³⁷ Prostate cancer ³⁷ Signal transduction PTEN pathway ²² Thyroid cancer ³⁷	12.88	CDKN1A CDKN1B CDKN2A PTEN RB1 TP53
5	Pathways in cancer ³⁷	12.83	CDKN1A CDKN1B CDKN2A CDKN2B PTEN RB1
6	Glioma ³⁷ Show member pathways EGFR tyrosine kinase inhibitor resistance ³⁷ Endocrine resistance ³⁷ Melanoma ³⁷ Non-small cell lung cancer ³⁷ Signaling Pathways in Glioblastoma ¹	12.75	CDKN1A CDKN1B CDKN2A CDKN2B PTEN RB1
7	Gastric cancer ³⁷ Show member pathways Breast cancer ³⁷ Hepatocellular carcinoma ³⁷	12.73	CDKN1A CDKN1B CDKN2A CDKN2B PTEN RB1
8	Chks in Checkpoint Regulation ⁶⁴ Show member pathways DNA Repair Mechanisms ⁶⁴ Estrogen-mediated S-Phase Entry ⁶⁴ G2-M Phase Transition ⁶⁴ Parkinson's Disease Pathway ⁶⁴ SREBP Proteolysis ⁶⁴	12.7	CDKN1A CDKN1B RB1 TP53 UBE2L3
9	Kaposi's sarcoma-associated herpesvirus infection ³⁷ Show member pathways Hepatitis B ³⁷	12.58	CDKN1A CDKN1B PTEN RB1 TP53
10	Mitotic G1-G1/S phases ⁶⁶ Show member pathways G1 to S cell cycle control ¹ G1/S Transition ⁶⁶	12.57	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53
11	DNA Damage ⁴	12.52	CDKN1A CDKN1B CDKN2A RB1 TP53
12	MicroRNAs in cancer ³⁷	12.51	CDKN1A CDKN1B CDKN2A FSCN1 PTEN TP53
13	Cytoskeletal Signaling ⁴	12.47	AMOT FSCN1 KRT10 KRT13 KRT20 KRT5
14	HTLV-I infection ³⁷	12.44	CDKN1A CDKN2A CDKN2B RB1 TP53
15	DNA Damage/Telomere Stress Induced Senescence ⁶⁶ Show member pathways Formation of Senescence-Associated Heterochromatin Foci (SAHF) ⁶⁶ Packaging Of Telomere Ends ⁶⁶ Signal transduction Activin A signaling regulation ²²	12.35	CDKN1A CDKN1B RB1 TP53
16	DNA Damage Response ¹ Show member pathways miRNA Regulation of DNA Damage Response ¹ p53 signaling pathway ³⁷	12.34	CDKN1A CDKN1B CDKN2A PTEN RB1 TP53
17	Cell cycle ¹ ³⁷	12.31	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53
18	Epstein-Barr virus infection ³⁷	12.29	CDKN1A CDKN1B RB1 TP53
19	Cyclins and Cell Cycle Regulation ⁶⁴ Show member pathways Cell Cycle Control by BTG Proteins ⁶⁴ Cyclin D associated events in G1 ⁶⁶ G1 Phase ⁶⁶ G1-S Phase Transition ⁶⁴ Phosphorylation of proteins involved in G1/S transition by active Cyclin E-Cdk2 complexes ⁶⁶	12.28	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53
20	p53 Signaling ⁶⁴ Show member pathways p53 Pathway ⁶⁷	12.26	CDKN1A PTEN RB1 TP53
21	Cell cycle Role of SCF complex in cell cycle regulation ²² Show member pathways Cell cycle ESR1 regulation of G1/S transition ²² Cell cycle Regulation of G1/S transition (part 1) ²² Immune response MIF-JAB1 signaling ²²	12.23	CDKN1A CDKN1B CDKN2A CDKN2B RB1
22	AKT Signaling Pathway ⁶⁷	12.15	CDKN1A CDKN1B PTEN TP53
23	FoxO signaling pathway ³⁷ Show member pathways PLK2 and PLK4 events ¹ Polo-like kinase signaling events in the cell cycle ¹	12.1	CDKN1A CDKN1B CDKN2B PTEN
24	Viral carcinogenesis ³⁷	12.1	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53
25	Cellular senescence (KEGG) ³⁷	12.09	CDKN1A CDKN2A CDKN2B PTEN RB1 TP53
26	Direct p53 effectors ¹	12.08	CDKN1A PTEN RB1 TP53
27	SMAD Signaling Network ⁶⁴	12.06	CDKN1A CDKN2A RB1 TP53 UBE3A
28	Development IGF-1 receptor signaling ²² Show member pathways Signal transduction AKT signaling ²²	12.05	CDKN1A CDKN1B PTEN TP53
29	Keratinization ⁶⁶ Show member pathways Formation of the cornified envelope ⁶⁶	12.01	FLG IVL KRT10 KRT13 KRT14 KRT20
30	Cytoskeleton remodeling Neurofilaments ²² Show member pathways Cytoskeleton remodeling Keratin filaments ²²	11.97	KRT13 KRT14 KRT5 KRT8
31	DNA Damage Response (only ATM dependent) ¹	11.97	CDKN1A CDKN1B CDKN2A PTEN TP53
32	TP53 Regulates Transcription of Cell Cycle Genes ⁶⁶ Show member pathways TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain ⁶⁶ TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest ⁶⁶ TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest ⁶⁶	11.9	CDKN1A CDKN1B TP53
33	Androgen receptor signaling pathway ¹	11.89	CDKN1A PTEN RB1 UBE3A
34	Glioblastoma Multiforme ⁶⁴	11.89	CDKN1A CDKN1B CDKN2A PTEN RB1 TP53
35	Retinoblastoma (RB) in Cancer ¹	11.86	CDKN1A CDKN1B RB1 TP53
36	Glucocorticoid receptor regulatory network ¹	11.82	CDKN1A KRT14 KRT5 TP53
37	Senescence and Autophagy in Cancer ¹	11.82	CDKN1A CDKN1B CDKN2A PTEN RB1 TP53
38	Bladder cancer ³⁷ ¹	11.76	CDKN1A CDKN2A RB1 TP53
39	Primary Focal Segmental Glomerulosclerosis FSGS ¹	11.75	CDKN1A CDKN1B KRT8
40	E2F transcription factor network ¹	11.74	CDKN1A CDKN1B RB1
41	Platinum drug resistance ³⁷	11.74	CDKN1A CDKN2A TP53
42	Validated targets of C-MYC transcriptional repression ¹	11.65	CDKN1A CDKN1B CDKN2B
43	Regulation of retinoblastoma protein ¹	11.6	CDKN1A CDKN1B RB1
44	Small cell lung cancer ³⁷	11.6	CDKN1A CDKN1B CDKN2B PTEN RB1 TP53
45	Photodynamic therapy-induced AP-1 survival signaling. ¹	11.56	CDKN1A CDKN2A RB1 TP53
46	miRNAs involved in DNA damage response ¹	11.55	CDKN1A CDKN1B TP53
47	Aryl Hydrocarbon Receptor ¹	11.53	CDKN1A CDKN1B RB1
48	Oncogene Induced Senescence ⁶⁶	11.32	CDKN2A CDKN2B TP53
49	Inhibition of Ribosome Biogenesis by p14(ARF) ⁶⁴	11.14	CDKN2A RB1 TP53
50	TP53 Network ¹ Show member pathways Activation, translocation and oligomerization of BAX ⁶⁶	11.14	CDKN1A CDKN2A TP53

Sources

GO Terms for Papilloma

Cellular components related to Papilloma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	PML body	GO:0016605	9.58	PTEN RB1 TP53
2	cytosol	GO:0005829	9.58	AMOT CDKN1A CDKN1B CDKN2A CDKN2B FLG
3	keratin filament	GO:0045095	9.56	KRT13 KRT14 KRT5 KRT8
4	cornified envelope	GO:0001533	9.54	FLG IVL KRT10
5	intermediate filament	GO:0005882	9.5	FLG KRT10 KRT13 KRT14 KRT20 KRT5
6	cytoplasm	GO:0005737	10.2	CDKN1A CDKN1B CDKN2A CDKN2B FSCN1 IVL
7	nucleus	GO:0005634	10.06	AMOT CDKN1A CDKN1B CDKN2A CDKN2B FLG

Biological processes related to Papilloma according to GeneCards Suite gene sharing:

(show all 27)

#	Name	GO ID	Score	Top Affiliating Genes
1	negative regulation of cell proliferation	GO:0008285	9.91	CDKN1A CDKN1B CDKN2A CDKN2B PTEN RB1
2	negative regulation of cell growth	GO:0030308	9.85	CDKN1A CDKN1B CDKN2A TP53
3	G1/S transition of mitotic cell cycle	GO:0000082	9.83	CDKN1A CDKN1B CDKN2A RB1
4	Ras protein signal transduction	GO:0007265	9.8	CDKN1A CDKN2A RB1 TP53
5	keratinocyte differentiation	GO:0030216	9.79	FLG IVL KRT10
6	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	GO:0006977	9.78	CDKN1A CDKN1B TP53
7	negative regulation of epithelial cell proliferation	GO:0050680	9.78	CDKN1B CDKN2B PTEN RB1
8	peptide cross-linking	GO:0018149	9.77	FLG IVL KRT10
9	protein kinase B signaling	GO:0043491	9.74	CDKN1A CDKN1B PTEN
10	negative regulation of G1/S transition of mitotic cell cycle	GO:2000134	9.73	CDKN1A CDKN2B PTEN RB1
11	negative regulation of vascular smooth muscle cell proliferation	GO:1904706	9.71	CDKN1A CDKN1B PTEN
12	negative regulation of cyclin-dependent protein serine/threonine kinase activity	GO:0045736	9.69	CDKN1A CDKN1B CDKN2A
13	mitotic cell cycle arrest	GO:0071850	9.63	CDKN1A CDKN1B
14	response to arsenic-containing substance	GO:0046685	9.63	CDKN1A PTEN
15	replicative senescence	GO:0090399	9.63	CDKN1A CDKN2A TP53
16	cell cycle arrest	GO:0007050	9.63	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53
17	hemidesmosome assembly	GO:0031581	9.62	KRT14 KRT5
18	hepatocyte apoptotic process	GO:0097284	9.62	KRT8 RB1
19	regulation of cyclin-dependent protein serine/threonine kinase activity	GO:0000079	9.62	CDKN1A CDKN1B CDKN2B PTEN
20	prostate gland growth	GO:0060736	9.6	PTEN UBE3A
21	signal transduction by p53 class mediator	GO:0072331	9.58	CDKN1A TP53
22	negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	GO:0031658	9.58	CDKN2A CDKN2B PTEN
23	negative regulation of cyclin-dependent protein kinase activity	GO:1904030	9.56	CDKN1A CDKN1B
24	negative regulation of phosphorylation	GO:0042326	9.56	CDKN1A CDKN1B CDKN2A CDKN2B
25	keratinization	GO:0031424	9.5	IVL KRT10 KRT13 KRT14 KRT20 KRT5
26	cornification	GO:0070268	9.23	FLG IVL KRT10 KRT13 KRT14 KRT20
27	cell cycle	GO:0007049	10.06	CDKN1A CDKN1B CDKN2A CDKN2B RB1 TP53

Molecular functions related to Papilloma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	protein kinase binding	GO:0019901	9.63	CDKN1A CDKN1B CDKN2A CDKN2B PTEN TP53
2	disordered domain specific binding	GO:0097718	9.43	CDKN2A RB1 TP53
3	structural molecule activity	GO:0005198	9.35	FLG IVL KRT10 KRT13 KRT8
4	cyclin-dependent protein serine/threonine kinase inhibitor activity	GO:0004861	8.92	CDKN1A CDKN1B CDKN2A CDKN2B
5	protein binding	GO:0005515	10.28	AMOT CDKN1A CDKN1B CDKN2A CDKN2B FLG

Sources

Sources for Papilloma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia

Papilloma

Aliases & Classifications for Papilloma

MalaCards integrated aliases for Papilloma:

Classifications:

External Ids:

Summaries for Papilloma

Related Diseases for Papilloma

Diseases related to Papilloma via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Papilloma:

Symptoms & Phenotypes for Papilloma

MGI Mouse Phenotypes related to Papilloma:

Drugs & Therapeutics for Papilloma

FDA approved drugs:

Drugs for Papilloma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Inferred drug relations via UMLS 73 / NDF-RT 51 :

Genetic Tests for Papilloma

Anatomical Context for Papilloma

MalaCards organs/tissues related to Papilloma:

Publications for Papilloma

Articles related to Papilloma:

Genes for Papilloma

Genes related to Papilloma (0 elite genes):

Variations for Papilloma

Expression for Papilloma

Pathways for Papilloma

Pathways related to Papilloma according to GeneCards Suite gene sharing:

GO Terms for Papilloma

Cellular components related to Papilloma according to GeneCards Suite gene sharing:

Biological processes related to Papilloma according to GeneCards Suite gene sharing:

Molecular functions related to Papilloma according to GeneCards Suite gene sharing:

Sources for Papilloma

Inferred drug relations via UMLS ⁷³ / NDF-RT ⁵¹ :